Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Withdrawn Phase 4 Interventional Accepts healthy volunteers

Trial of Treatment of Atopic Dermatitis With Concurrent Altabax® and Topical Low-Potency Corticosteroids Versus Low-Potency Corticosteroid Mono-therapy

ClinicalTrials.gov ID: NCT00871208

Public ClinicalTrials.gov record NCT00871208. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 23, 2026, 6:43 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized, Placebo-Controlled Trial of Treatment of Atopic Dermatitis With Concurrent Altabax® and Topical Low-Potency Corticosteroids vs. Low-Potency Corticosteroid Mono-therapy

Study identification

NCT ID
NCT00871208
Recruitment status
Withdrawn
Study type
Interventional
Phase
Phase 4
Lead sponsor
St. Luke's-Roosevelt Hospital Center
Other
Enrollment
Not listed

Conditions and interventions

Interventions

  • Altabax (R) Drug
  • Vehicle and Locoid lipocream (R) Drug

Drug

Eligibility (public fields only)

Age range
9 Months to 17 Years
Sex
All
Healthy volunteers
Accepts healthy volunteers

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2009
Primary completion
Apr 30, 2010
Completion
Apr 30, 2010
Last update posted
May 11, 2015

2009 – 2010

United States locations

U.S. sites
3
U.S. states
1
U.S. cities
1
Facility City State ZIP Site status
Department of Dermatology, Beth Israel Medical Center New York New York 10003
Department of Dermatology, Roosevelt Hospital New York New York 10019
Department of Dermatology, St. Luke's-Roosevelt-Hospital Center New York New York 10025

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00871208, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 11, 2015 · Synced Jul 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00871208 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →